CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

eperisone

Small moleculeexperimental

Eperisone is an antispasmodic drug. — Wikipedia

Clinical trial activity

12 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
5
Phase 3
3
Phase 4
0

Earliest trial started Apr 1, 2006 (NCT00327730)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1
Mol. weight
259.39 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, hydrochloride
  • (2rs)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
  • (2rs)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
  • 4-empp
  • (4'-ethyl-2-methyl-3-piperidino)propiophenone
  • dw1030
  • e-0646
  • eperison
  • eperison
  • eperisona
  • eperisona
  • eperisone
  • eperisone
  • eperisone
  • eperisone
  • eperisone
  • eperisone
  • eperisone
  • eperisone
  • (+/-)-eperisone
  • epérisone
  • epérisone
  • eperisone hcl
  • eperisone hcl
  • eperisone hcl
  • eperisone hydrochloride
  • eperisone hydrochloride
  • eperisone hydrochloride
  • eperisonum
  • eperisonum
  • epirisone
  • hcp1104

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06395155Phase 1Oct 26, 2023Chonbuk National University, Daehwa Pharmaceutical Co., Ltd.
NCT03337607N/ANov 13, 2017Ludwig Maximilians University, Zhejiang University
NCT03424707Phase 2Mar 4, 2016Daewon Pharmaceutical Co., Ltd.
NCT02380976Phase 1Oct 1, 2015Daewon Pharmaceutical Co., Ltd.
NCT02289274Phase 1Dec 1, 2014Navipharm Corporation, University of Ulsan
NCT02071381Phase 1Apr 1, 2014Daewon Pharmaceutical Co., Ltd.
NCT02040415Phase 3Mar 1, 2014Daewon Pharmaceutical Co., Ltd.
NCT01869985Phase 1Aug 1, 2013Hanmi Pharmaceutical
NCT01806818Phase 2Feb 1, 2013Hanmi Pharmaceutical, Yonsei University
NCT01306318N/AFeb 1, 2011Eisai
NCT01300312Phase 3Feb 1, 2011Eisai
NCT00327730Phase 3Apr 1, 2006Eisai
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Daewon Pharmaceutical Co., Ltd.For profit4432014
EisaiFor profit3322006
Hanmi PharmaceuticalFor profit2222013
Chonbuk National UniversityAcademic/Hospital1012023
Daehwa Pharmaceutical Co., Ltd.For profit1112023
Ludwig Maximilians UniversityAcademic/Hospital1012017
Navipharm CorporationFor profit1112014
University of UlsanAcademic/Hospital1012014
Yonsei UniversityAcademic/Hospital1012013
Zhejiang UniversityAcademic/Hospital1112017
10 organizations
Page 1 / 1